Psychiatry on the Front Lines of a Pandemic - Corona and Mental Health Part 3

Linda Chokroverty, MD, is the attending physician at the Montefiore Health Systems in Bronx, NY; Assistant Professor of Psychiatry and Behavioral Sciences and Pediatrics at the Albert Einstein College of Medicine; and Co-Chair of the Disaster and Trauma Issues Committee with the American Academy of Child and Adolescent Psychiatry. In this episode she describes her experiences working with COVID19 providers and advice for clinicians who may face similar issues during the pandemic.

 

https://www.thecarlatreport.com/blog/psychiatry-on-the-front-lines-of-a-pandemic/?MailingID=110

Author
Joshua Feder, M.D. Dr. Feder's Blog

You Might Also Enjoy...

How Effective is Atomoxetine in Children and Adolescents?

Since its FDA approval in 2002, Atomoxetine (brand name Strattera) has become a second or third line option (after stimulants and sometimes after central alpha agonists) for ADHD in both children and adults. Does it work? Listen and find out!

Discussing Stimulant Treatment with Parents

ADHD is one of the most treatable conditions in psychiatry if patients adhere to medication regimens. So, why are parents so resistant to stimulant medications and how can we approach these misconceptions?

Treating Children of Divorce

Each year in the US, there are about 1.04 million divorces, affecting about 800,000 children. How can we navigate the complexities of treating a child with divorce?